Truist Financial Cuts HCA Healthcare (NYSE:HCA) Price Target to $390.00

HCA Healthcare (NYSE:HCA) had its price objective cut by Truist Financial from $430.00 to $390.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other research firms also recently commented on HCA. Morgan Stanley reduced their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Oppenheimer lifted their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Barclays reduced their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Stock Performance

Shares of HCA opened at $311.19 on Monday. HCA Healthcare has a 12-month low of $276.50 and a 12-month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a market cap of $78.82 billion, a PE ratio of 13.97, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. The company’s 50 day simple moving average is $323.68 and its 200-day simple moving average is $354.18.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were given a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Activity at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

Several large investors have recently added to or reduced their stakes in the business. MML Investors Services LLC lifted its holdings in shares of HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares during the period. Meritage Group LP acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $150,548,000. Alpha DNA Investment Management LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth $869,000. NRI Wealth Management LC purchased a new stake in HCA Healthcare during the fourth quarter valued at about $2,896,000. Finally, Chiron Investment Management LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter worth about $3,548,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.